1. Sweden Stocks

  2. •

    Technology services

  3. •

    Packaged software
ScandiDos AB

ScandiDos AB

0.76
SEK
-0.03
(-3.80%)
-0.16EPS
47.32MMarket Cap
Dec 15Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
3.14
2.86
2.04
2.05
1.92
2.01
1.6
1.47
1.62
1.55
1.51
1.55
1.08
1
Basic EPS, GAAP
-0.34
-1.28
-0.87
-0.57
-0.44
-0.73
-0.37
-0.03
-0.21
-0.23
-0.37
0.01
-0.07
-0.16
Free Cash Flow per Basic Share
-0.87
-1.57
-1.34
-0.68
-0.48
-0.9
-0.27
0.1
-0.06
-0.41
-0.04
-0.24
-0.08
-0.13
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
3.28
2.05
1.85
1.92
1.85
1.13
1.28
1.25
1.03
1.05
1.11
0.9
0.84
0.76
Tangible Book Value per Share
1.51
-0.31
0.03
0.63
0.71
-0.17
0.38
0.35
0.2
0.31
0.5
0.4
0.29
0.31
Basic Weighted Avg Shares
12
12
16
23
26
24
36
41
36
40
40
40
50
50
Sales/Revenue/Turnover
39
33
34
47
51
49
57
60
58
62
60
62
54
50
Operating Margin (%)
-9.18
-46.84
-40.39
-26.01
-23.34
-33.3
-21.12
-4.5
-13.21
-13.37
-13.51
0.99
-5.51
-15.14
Depreciation Expense
- -
- -
1
5
5
4
4
4
5
5
2
2
2
2
Net Income, GAAP
-4
-15
-14
-13
-12
-18
-13
-1
-7
-9
-15
- -
-3
-8
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-10.85
-44.6
-42.42
-27.75
-22.87
-36.38
-22.93
-2.33
-12.72
-14.82
-24.24
0.53
-6.34
-16.42
Working Capital
18
-4
3
16
19
-4
13
12
7
17
23
18
11
16
LT Debt
- -
- -
3
2
1
1
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
40
25
32
44
47
29
46
45
37
42
44
45
42
47
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1.38
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1.68
- -
- -
Return on Common Equity (%)
-16.57
-44.61
-49.67
-34.62
-25.53
-47.24
-35.08
-3.06
-17.82
-23.13
-34.09
0.73
-7.93
- -

Capital Structure

SEK

•

in mil. unless spec.
Jan'26
Apr'26
Jul'27
ST Debt
- -
- -
2
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
50
50
62
Market Capitalization
- -
- -
47

Working Capital

SEK

•

in mil. unless spec.
Jan'26
Apr'26
Jul'27
Total Current Assets
38
35
41
Cash, Cash Equivalents & STI
6
4
16
Accounts Receivable, Net
9
10
3
Inventories
18
18
19
Total Current Liabilities
26
24
24
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
2
Deferred Revenue
- -
- -
- -

Growth Rates

SEK

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.89%
-1.04%
-7.38%
Free Cash Flow
67.32%
169.22%
-57.15%
Net Income, GAAP
-82.48%
-148.66%
-1,150.46%
Sales/Revenue/Turnover
5.75%
-1.79%
-12.32%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
13
16
18
15
62
2026
- -
15
14
14
54
2027
7
- -
- -
- -
- -

Quarterly Earnings Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.01
0.01
0.02
-0.01
0.01
2026
- -
0.01
-0.03
- -
-0.07
2027
-0.14
- -
- -
- -
- -

Quarterly Dividends Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Olof Stranding
Full Time Employees
25
Sector
Technology services
Industry
Packaged software
Address
Uppsala Science Park Uppsala UP Sweden 751 83
IPO Date
Apr 11, 2014
Website
scandidos.com
Similar Companies
Microsoft Corporation (NASDAQ:MSFT)
Palantir Technologies Inc. (NASDAQ:PLTR)
Nebius Group N.V. (NASDAQ:NBIS)
Oracle Corporation (NYSE:ORCL)
CoreWeave, Inc. (NASDAQ:CRWV)
ServiceNow, Inc. (NYSE:NOW)
Business
ScandiDos AB (publ) (SDOS.ST) develops and provides advanced measurement systems and software for quality assurance and dosimetry in modern radiation therapy for cancer treatment; its core Delta4 family includes Delta4 Phantom+ for comprehensive QA of procedures such as VMAT, RapidArc, IMRT, and Tomotherapy, Delta4 Phantom+ MR for MRI-guided radiation therapy, Delta4 HexaMotion motion platform simulating tumor movement in six dimensions, Delta4 Insight using Monte Carlo dose engine for treatment plan verification, and associated software options covering machine QA and dynamic treatments; the company also offers installation, service agreements, and customer support through subsidiaries in the US, France, and China plus approximately 40 international distributors. Founded in 2001 and headquartered in Uppsala Science Park, Sweden, ScandiDos operates globally with customers in over 50 countries, targeting radiotherapy clinics seeking precision in personalized treatments from leading equipment manufacturers. In 2024, the company completed a rights issue in April to bolster finances, achieved positive EBITDA and net income in Q2 (August-October) amid cost reductions from prior savings programs including lower personnel expenses, delivered systems to key markets like Japan, India, Spain, and Italy including Delta4 Phantom+ to Hospital Central de la Defensa Gómez Ulla in Madrid—which became a reference center in November—and Ospedale Mons. Dimiccoli in Barletta for Varian TrueBeam integration, participated in major trade shows such as ASTRO in Washington D.C., and managed inventory adjustments alongside repayments of pandemic-related tax deferrals while investing in R&D for measurement phantoms.